Šiaulių Bankas starts disseminating a two-year bond issue of InMedica
The network of medical clinics InMedica enters the bond market and seeks to borrow up to EUR 5 million for a 2 year period. The interest rate of the bonds will range between 5% and 6%. The final bond interest rate will be determined by the company after collecting all investor's purchase applications. In total, investors can acquire 50 thousand units of the company bonds. The nominal value of a single bond totals to EUR 100. The bond issue will be disseminated over several stages with the first stage falling between 27 November and 13 December. These debt securities will be listed on First North, an alternative securities market administered by Nasdaq Vilnius.
“We are starting to build the history of the company in the capital markets and with this step we will seek to ensure the trust of up to 100 new investors. We are the first company in the Lithuanian medical sector to raise funds through a public bond issue,” - said Laura Penikienė, Director General of InMedica.
According to L. Penikienė, the main purpose of the bond issue is to finance new development projects. The company has been expanding rapidly with the acquisition of 5 clinics in the last two years and the launch of a modern day surgery centre in Vilnius this year.
Today InMedica operates a network of 19 clinics in various cities across the country providing family medicine, physician, dental and other healthcare services. 75 thousand registered clients make InMedica one of the largest private medical centres in Lithuania with over 600 employees.
More information on acquisition of the bonds of InMedica is available here.
In case of any queries regarding the purchase of bonds, please contact Šiaulių Bankas financial brokers by e-mailing to [email protected].
